Tenet Healthcare (THC) Tops Q1 EPS by 66c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q1 EPS of $4.82, $0.66 better than the analyst estimate of $4.16. Revenue for the quarter came in at $5.37 billion versus the consensus estimate of $5.39 billion.

GUIDANCE:

Tenet Healthcare sees FY2026 EPS of $16.38-$18.68, versus the consensus of $17.19. Tenet Healthcare sees FY2026 revenue of $21.5-22.3 billion, versus the consensus of $22.02 billion.

Tenet Healthcare sees Q2 2026 revenue of $5.5-5.7 billion, versus the consensus of $5.44 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight